Literature DB >> 19933939

Persistent diastolic dysfunction late after valve replacement in severe aortic regurgitation.

Bruno Villari1, Samuel Sossalla, Quirino Ciampi, Bruno Petruzziello, Juraj Turina, Jakob Schneider, Marko Turina, Otto M Hess.   

Abstract

BACKGROUND: Regression of left ventricular (LV) hypertrophy with normalization of diastolic function has been reported in patients with aortic stenosis late after aortic valve replacement (AVR). The purpose of the present study was to evaluate the effect of AVR on LV function and structure in chronic aortic regurgitation early and late after AVR. METHODS AND
RESULTS: Twenty-six patients were included in the present analysis. Eleven patients with severe aortic regurgitation were studied before, early (21 months) and late (89 months) after AVR through the use of LV biplane angiograms, high-fidelity pressure measurements, and LV endomyocardial biopsies. Fifteen healthy subjects were used as controls. LV systolic function was determined from biplane ejection fraction and midwall fractional shortening. LV diastolic function was calculated from the time constant of LV relaxation, peak filling rates, and myocardial stiffness constant. LV structure was assessed from muscle fiber diameter, interstitial fibrosis, and fibrous content. LV muscle mass decreased significantly by 38% early and 55% late after surgery. Ejection fraction was significantly reduced preoperatively and did not change after AVR (P=NS). LV relaxation was significantly prolonged before surgery (89+/-28 ms) but was normalized late after AVR (42+/-14 ms). Early and late peak filling rates were increased preoperatively but normalized postoperatively. Diastolic stiffness constant was increased before surgery (22+/-6 versus 9+/-3 in control subjects; P=0.0003) and remained elevated early and late after AVR (23+/-4; P=0.002). Muscle fiber diameter decreased significantly after AVR but remained increased at late follow-up. Interstitial fibrosis was increased preoperatively and increased even further early but decreased late after AVR. Fibrosis was positively linearly correlated to myocardial stiffness and inversely correlated to LV ejection fraction.
CONCLUSIONS: Patients with aortic regurgitation show normalization of macroscopic LV hypertrophy late after AVR, although fiber hypertrophy persists. These changes in LV myocardial structure late after AVR are accompanied by a change in passive elastic properties with persistent diastolic dysfunction.

Entities:  

Mesh:

Year:  2009        PMID: 19933939     DOI: 10.1161/CIRCULATIONAHA.108.812685

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Rad GTPase inhibits cardiac fibrosis through connective tissue growth factor.

Authors:  Ji Zhang; Lin Chang; Chunlei Chen; Meiling Zhang; Yan Luo; Milton Hamblin; Luis Villacorta; Jing-Wei Xiong; Y Eugene Chen; Jifeng Zhang; Xiaojun Zhu
Journal:  Cardiovasc Res       Date:  2011-03-07       Impact factor: 10.787

Review 2.  Challenges and opportunities in improving left ventricular remodelling and clinical outcome following surgical and trans-catheter aortic valve replacement.

Authors:  Xu Yu Jin; Mario Petrou; Jiang Ting Hu; Ed D Nicol; John R Pepper
Journal:  Front Med       Date:  2021-05-28       Impact factor: 4.592

3.  Sleep-disordered breathing in patients undergoing transfemoral aortic valve implantation for severe aortic stenosis.

Authors:  Zisis Dimitriadis; Marcus Wiemer; Werner Scholtz; Lothar Faber; Cornelia Piper; Thomas Bitter; Ippokratis Messaritakis; Kevin Bullert; Jochen Boergermann; Georg Kleikamp; Christian Prinz; Dieter Horstkotte; Olaf Oldenburg
Journal:  Clin Res Cardiol       Date:  2013-08-21       Impact factor: 5.460

4.  Left ventricular diastolic function in children and young adults with congenital aortic valve disease.

Authors:  Kevin G Friedman; Doff B McElhinney; Jonathan Rhodes; Andrew J Powell; Steven D Colan; James E Lock; David W Brown
Journal:  Am J Cardiol       Date:  2012-10-24       Impact factor: 2.778

Review 5.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

Review 6.  Myocardial hypertrophy and its role in heart failure with preserved ejection fraction.

Authors:  Frank R Heinzel; Felix Hohendanner; Ge Jin; Simon Sedej; Frank Edelmann
Journal:  J Appl Physiol (1985)       Date:  2015-07-16

7.  Diastolic dysfunction and arrhythmias caused by overexpression of CaMKIIδ(C) can be reversed by inhibition of late Na(+) current.

Authors:  Samuel Sossalla; Ulrike Maurer; Hanna Schotola; Nico Hartmann; Michael Didié; Wolfram-H Zimmermann; Claudius Jacobshagen; Stefan Wagner; Lars S Maier
Journal:  Basic Res Cardiol       Date:  2010-12-21       Impact factor: 17.165

8.  Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade.

Authors:  Kalkidan Bishu; Ozgur Ogut; Sudhir Kushwaha; Selma F Mohammed; Tomohito Ohtani; Xiaolei Xu; Frank V Brozovich; Margaret M Redfield
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

9.  Pre- and postoperative left atrial and ventricular volumetric and deformation analyses in severe aortic regurgitation.

Authors:  Maria J Eriksson; Kenneth Caidahl; Jonas Jenner; Ali Ilami; Johan Petrini; Per Eriksson; Anders Franco-Cereceda
Journal:  Cardiovasc Ultrasound       Date:  2021-02-14       Impact factor: 2.062

10.  Reverse remodelling after aortic valve replacement for chronic aortic regurgitation.

Authors:  Ayumi Koga-Ikuta; Satsuki Fukushima; Naonori Kawamoto; Tetsuya Saito; Yusuke Shimahara; Shin Yajima; Naoki Tadokoro; Takashi Kakuta; Toshihiro Fukui; Tomoyuki Fujita
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-06-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.